Jallal Bahija
- SEC CIK
- 0001730038
In the past year, 1 open-market sale filing worth $371.2K and no purchases.
Current role at each company
- ELV Elevance Health, Inc.Directoras of May 15, 2026
- IMCR Immunocore Holdings plcCHIEF EXECUTIVE OFFICERas of Feb 19, 2026
- AVBP ArriVent BioPharma, Inc.Directoras of Jan 29, 2024
- GH Guardant Health, Inc.Directoras of Jun 17, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $371.2K
- 1 filing
- Net
- −$371.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jallal Bahija as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
IMCR Immunocore Holdings plc
CHIEF EXECUTIVE OFFICER1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 19, 2026 (view filing) | Feb 18 | 1 day | Jallal BahijaCHIEF EXECUTIVE OFFICER | SSale | −11.5K | $32.35 | −$371.2K | −48.2%12.3K after |